Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Saskia Leserer"'
Autor:
Saskia Leserer, Theresa Graf, Martina Franke, Rashit Bogdanov, Esteban Arrieta-Bolaños, Ulrike Buttkereit, Nils Leimkühler, Katharina Fleischhauer, Hans Christian Reinhardt, Dietrich W. Beelen, Amin T. Turki
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
IntroductionAnti-T-lymphocyte globulin (ATG) or post-transplant cyclophosphamide (PTCy) prevent graft-versus-host disease (GVHD) after hematopoietic cell transplantation (HCT), yet individual patients benefit differentially.MethodsGiven the sparse co
Externí odkaz:
https://doaj.org/article/e5b21102b5c742e58cc3115e8f0d471b
Autor:
Saskia Leserer, Esteban Arrieta-Bolaños, Ulrike Buttkereit, Dietrich W. Beelen, Amin T. Turki
Publikováno v:
Cells, Vol 10, Iss 12, p 3318 (2021)
The incidence and severity of viral complications after cellular therapy are highly variable. Recent publications describe relevant interactions between the human Cytomegalovirus (CMV) and host immunity in recipients of allogeneic hematopoietic cell
Externí odkaz:
https://doaj.org/article/97c5ab60039445f0877334099cbdec38
Autor:
Nikolaos Tsachakis-Mück, Luisa Betke, Dietrich W. Beelen, Katharina Fleischhauer, Pietro Crivello, Saskia Leserer, Mirko Trilling, Ferras Alashkar, Nils Bastian Leimkühler, Amin T. Turki, Tobias Liebregts
Publikováno v:
Blood Advances
Key Points The impact of CMV reactivation on hematologic relapse after HCT is modulated by AML stage (CR1 or advanced) and in vivo T cell depletion.Following CMV reactivation, NRM was increased in CR1 patients without ATG, but not in patients with AT
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81397ac6726885b97ffaeeccb9dc4a1c
https://www.ncbi.nlm.nih.gov/pubmed/34619756
https://www.ncbi.nlm.nih.gov/pubmed/34619756
Autor:
Turki, Saskia Leserer, Esteban Arrieta-Bolaños, Ulrike Buttkereit, Dietrich W. Beelen, Amin T.
Publikováno v:
Cells; Volume 10; Issue 12; Pages: 3318
The incidence and severity of viral complications after cellular therapy are highly variable. Recent publications describe relevant interactions between the human Cytomegalovirus (CMV) and host immunity in recipients of allogeneic hematopoietic cell
Autor:
Evren Bayraktar, Esteban Arrieta-Bolaños, Amin T. Turki, Rashit Bogdanov, Rudolf S. Ross, Saskia Leserer, Nikolaos Tsachakis-Mück, Katharina Fleischhauer, Michael Koldehoff, Mirko Trilling, Fabienne Maaßen, Pietro Crivello, Dietrich W. Beelen
Even in the era of PCR-based monitoring, prophylaxis, and preemptive therapy, Cytomegalovirus (CMV) viremia remains a relevant cause of non-relapse mortality (NRM) after allogeneic hematopoietic cell transplantation (HCT). However, studies using bina
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90cb083a60dd0b6fa1f13e8c44210d21
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85100866144
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85100866144
Autor:
Markus Ditschkowski, Nikolaos Tsachakis-Mück, Amin T. Turki, Lambros Kordelas, Dietrich W. Beelen, Michael Koldehoff, Nina K. Steckel, Rudolf Trenschel, Saskia Leserer, Hellmut Ottinger, Evren Bayraktar, Katharina Fleischhauer, Tobias Liebregts, Vesna Klisanin
Prophylaxis of graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HCT) remains challenging. Because prospective randomized trials of in-vivo T cell depletion using anti-T-lymphocyte globulin (ATLG) in addition
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e65aea4455b79b0c377798d52efeefa
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85075486303
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85075486303
Autor:
J.-H. Yi, Amin T. Turki, Dietrich W. Beelen, Saskia Leserer, L. Kasperidus, Evren Bayraktar, Rashit Bogdanov
Publikováno v:
HemaSphere. 3:328-329
Autor:
Dietrich W. Beelen, Melanie Fiedler, Rashit Bogdanov, Tobias Liebregts, Saskia Leserer, Nikolaos Tsachakis-Mück, Evren Bayraktar, Ji-Hee Yi, Amin T. Turki, Nina K. Steckel
Publikováno v:
Blood. 132:3413-3413
Introduction After allogeneic cell transplantation (HCT) for acute myeloid leukemia (AML) relapse remains the main cause of morbidity and mortality. Relapse rates directly translate into patients' overall survival. The connection between early human